Heart Failure at the Shoe

September 25th, 2026


This conference has already taken place.


The Ohio State University Wexner Medical Center - Columbus, OH
1 Day Conference September 25th, 2026
6.25 AMA PRA Category 1 Credit™ Hours

Description

Dates and Times

Start: 9/25/2026 8:00 AM
End: 9/25/2026 3:30 PM

Objectives

At the conclusion of this continuing medical education activity participants should be able to:

1. Identify heart failure management strategies beyond the four pillars of guideline-directed medical therapy.
2. Describe key successful strategies in outpatient heart failure specialty programs (transition of care, wellness, and pharmacy).
3. Review pulmonary hypertension management associated with HFpEF.
4. Understand the role of right heart catheterization and hemodynamic profiling in evaluation of HFpEF.
5. Incorporate current clinical evidence in the assessment, treatment, and management of patients with myocardial disease (inflammatory/infiltrative cardiomyopathies).
6. Review emerging device-based technologies and multidisciplinary strategies across the structural heart, electrophysiology, and heart failure interface.
7. Identify current best practice for surgical management of heart failure patients.
8. Outline advances in cardiogenic shock management, early triage, and rapid access to temporary mechanical circulatory support and advanced therapies (LVAD and heart transplantation).
9. Recognize the need for palliative care among heart failure patients, when to refer, and describe strategies for management.
10. Explore special topics in heart failure including genetics, cardio-oncology, and arrhythmias.

Agenda

Pricing

Tier Price
Physician $0.00
Physician Assistant $0.00
Advanced Practice Provider $0.00
Nurse/Nurse Practitioner $0.00
Allied Health Professional $0.00
Other $0.00

Speakers

  • William Abraham, MD
    • Rewriting the Heart Failure Story: 30 Years of Progress
  • Indra Bole, MD
    • Stabilizing Cardiogenic Shock
    • The Changing Epidemiology of Heart Failure
  • Eryn Bryant, APRN
    • Novel Programs: Transitions of Care/ Heart Function Wellness Clinic
  • Brian Carlisle, MD
    • Heart Failure Palliative Care
  • Katherine Dodd, DO
    • Cardiogenic Shock: Collaboration Across Systems (Case Study)
    • Recognizing and Referring Advanced Heart Failure
  • Beth Foreman, DO
    • Managing HFrEF in 2026: Beyond Neurohormonal Blockade
  • Jordan Gavin, MD
    • Unexplained Dyspnea and the Role of Exercise Testing
  • Akash Goyal, MD
    • A New Era in Hypertrophic Cardiomyopathy
  • Ayesha Hasan, MD
    • Cardiogenic Shock: Collaboration Across Systems (Case Study)
    • Updates in Heart Transplantation
  • Matthew Henn, MD
    • Heart Failure and Surgical Management
  • Sarah Hill, PharmD
    • Pharmacy Managed Heart Failure Programs
  • Elie Homsy, MD
    • Updates in Pulmonary Hypertension
  • Jennifer Host, APRN
    • Novel Programs: Transitions of Care/ Heart Function Wellness Clinic
  • Elizabeth Jordan, Other
    • Heart Failure Genetics
  • Rami Kahwash, MD
    • Heart Failure and Electrophysiology
  • Mazier Khorsandi, Other
    • LVADs in 2026: An Evolving Therapy
  • Scott Lilly, MD
    • Heart Failure and Structural Heart
  • Alexandria Miller, MD
    • Unexplained Dyspnea and the Role of Exercise Testing
  • Vaiibhav Patel, MD
    • Cardiac Sarcoidosis: Recognition and Management
  • Adam Potter, MD
    • Cardio-Oncology
  • Greg Ruf, Other
    • Patient to Advocate: Journey through Heart Failure with Dilated Cardiomyopathy
  • Salvatore Savona, MD
    • Management of Dysrhythmias in Heart Failure
  • Sakima Smith, MD
    • Cardiac Inflammation caused by Tyrosine Kinase Inhibitors (TKI) and Novel Therapeutic Targets
  • Ajay Vallakati, MD
    • Cardiac Amyloidosis: Standard of Care and Beyond
  • Takuya Wada, MD
    • Approach to Temporary MCS in Cardiogenic Shock

Location

The Ohio State University Wexner Medical Center
Biomedical Research Tower
460 W. 12th Avenue
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Need help with this conference?

Please contact the conference coordinator listed below:

Ellen Yokoyama
Email: Ellen.Yokoyama@osumc.edu